Skip to main content

Articles

Page 1 of 17

  1. To identify recurrent venous thromboembolism (VTE) after discontinuation of anticoagulation in patients with isolated distal deep vein thrombosis based on its anatomic localization (axial or muscular veins).

    Authors: Wen-Tao Yang, Zhen-Yi Jin, Chun-Min Li, Jia-Hao Wen and Hua-Liang Ren
    Citation: Thrombosis Journal 2024 22:57
  2. Hypercoagulability emerges as a central pathological feature and clinical complication in nephrotic syndrome. Increased platelet activation and aggregability are closely related to hypercoagulability in nephro...

    Authors: Shi-Ping Na, Mei-Liang Ning, Ji-Fang Ma, Shuang Liang, Yan-Li Wang, Man-Shu Sui, Xiao-Fang Guo, Ying Ji, Hui-Yan Lyu, Xue-Ying Yuan and Yu-Shi Bao
    Citation: Thrombosis Journal 2024 22:56
  3. In recent years, extracorporeal membrane oxygenation (ECMO) has been increasingly used in critically ill patients with respiratory or cardiac failure. Heparin is usually used as anticoagulation therapy during ...

    Authors: Danyu Song, Yu Jin, Yang Zhang and Zhou Zhou
    Citation: Thrombosis Journal 2024 22:55
  4. Tuberculosis disease (TB) and tuberculosis infection (TBI) have been associated with increased risk of cardiovascular disease which may be connected to infection-related haemostatic changes. It is unknown if t...

    Authors: Hans Johan Niklas Lorentsson, Christina R. Clausen, Daniel Faurholt-Jepsen, Katrine Bagge Hansen, Sidse Graff Jensen, Rikke Krogh-Madsen, Per G. Hagelqvist, Pär I. Johansson, Tina Vilsbøll, Filip K. Knop and Pernille Ravn
    Citation: Thrombosis Journal 2024 22:54
  5. Platelet is enriched with Circular RNAs (circRNAs), with circFAM13B rank among the 10 most abundant circRNAs in platelets. The aim of the present study was to evaluate the predictive value of platelet-derived ...

    Authors: Yuting Zou, Yuyan Wang, Yanzhu Yao, Yangxun Wu, Chao Lv and Tong Yin
    Citation: Thrombosis Journal 2024 22:53
  6. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a profound global impact, with millions of confirmed cases and deaths worldwide...

    Authors: Kiyohito Hayashi, Daisuke Koyama, Yoichi Hamazaki, Takamichi Kamiyama, Shingo Yamada, Miki Furukawa, Yoshinori Tanino, Yoko Shibata and Takayuki Ikezoe
    Citation: Thrombosis Journal 2024 22:52
  7. The link between venous thromboembolism (VTE) and cancer is well known. VTE could be the initial sign of an occult malignancy. There are more diagnoses of cancer after an unprovoked VTE compared to a provoked ...

    Authors: Maria-Cristina Glodeanu, Victoria Mutruc, Camelia-Maria Apetrei, Manuela Ursaru, Laurentiu Sorodoc and Catalina Lionte
    Citation: Thrombosis Journal 2024 22:51
  8. About 13–25% of cerebral venous thrombosis (CVT) cases lack clear etiology, which may be associated with underlying genetic factors. This study aims to investigate genetic factors in CVT patients using whole e...

    Authors: Shaoying Wang, Ming Yao, Xinzhuang Yang, Yicheng Zhu and Bin Peng
    Citation: Thrombosis Journal 2024 22:50
  9. Pulmonary embolism (PE) is a life-threatening thromboembolic disease for which there is limited evidence for effective prevention and treatment. Our goal was to determine whether genetically predicted circulatin...

    Authors: Chen Jiang, Jianing Lin, Bin Xie, Meijuan Peng, Ziyu Dai, Suyin Mai and Qiong Chen
    Citation: Thrombosis Journal 2024 22:49
  10. Risks of recurrence and major bleeding with extended anticoagulation in Asian patients with venous thromboembolism (VTE) are similar to those in non-Asian patients but risks according to baseline risk factor p...

    Authors: Norikazu Yamada, Weiguo Fu, Zhenyu Shi, Ki-Hyuk Park, Hyo-Soo Kim, Xiangchen Dai, Anthonie WA Lensing, Akos F Pap, Tomoko Kohno, Tsubasa Tajima, Tadashi Watakabe and Tomoyuki Mitsumori
    Citation: Thrombosis Journal 2024 22:48
  11. Von Willebrand factor (vWF) plays a crucial role in hemostasis, acting as a key factor for platelet adhesion/aggregation and as a transport protein for coagulation factor VIII. vWF is secreted as a giant multi...

    Authors: Yuki Chiba, Kota Goto, Misako Suzuki, Hisanori Horiuchi and Mineji Hayakawa
    Citation: Thrombosis Journal 2024 22:46
  12. Clinical decision support systems (CDSS) have been utilized as a low-cost intervention to improve healthcare process measures. Thus, we aim to estimate CDSS efficacy to optimize adherence to oral anticoagulant...

    Authors: Ahmed Mazen Amin, Ramy Ghaly, Mohamed T. Abuelazm, Ahmed A. Ibrahim, Mohammad Tanashat, Moumen Arnaout, Obieda Altobaishat, Ahmed Elshahat, Basel Abdelazeem and Sudarshan Balla
    Citation: Thrombosis Journal 2024 22:45
  13. Recent guidelines recommend using direct oral anticoagulants (DOACs) as first-line agents in patients with non-valvular atrial fibrillation (NVAF). Research is currently investigating the use of Apixaban in un...

    Authors: Khalid Al Sulaiman, Ohoud Aljuhani, Hadeel Alkofide, Manal A. Aljohani, Hisham A. Badreldin, Mahasen Al Harbi, Ghalia Aquil, Raghad Alhajaji, Rahaf A. Alqahtani, Alaa Babonji, Maha Altuwayr, Asma A. Alshehri, Mashael Alfaifi, Abdullah F. Alharthi, Mohammed Alzahrani, Tareq Al Sulaiman…
    Citation: Thrombosis Journal 2024 22:43
  14. This study aimed to evaluate the association of antiphospholipid antibodies (aPL) and conventional markers of coagulation with ischemic and bleeding risk in patients with atrial fibrillation (AF) undergoing pe...

    Authors: Diona Gjermeni, Viktoria Anfang, Sofia Szabó, Hannah Vetter, Ana C. Venhoff, Stefan Leggewie, David Hesselbarth, Dietmar Trenk, Martin Buechsel, Dirk Westermann and Christoph B. Olivier
    Citation: Thrombosis Journal 2024 22:42
  15. Currently published studies have not observed consistent results on the efficacy and safety of direct oral anticoagulants (DOACs) use in patients with chronic kidney disease (CKD) combined with atrial fibrilla...

    Authors: Yaodi Li, Shuyi Wu, Jintuo Zhou and Jinhua Zhang
    Citation: Thrombosis Journal 2024 22:40
  16. The management of acute pulmonary embolism (PE) has become increasingly complex with the expansion of advanced therapeutic options, resulting in the development and widespread adoption of multidisciplinary Pul...

    Authors: Tiffany A. Gardner, Alexandra Fuher, August Longino, Eric M. Sink, James Jurica, Bryan Park, Jonathan Lindquist, Todd M. Bull and Peter Hountras
    Citation: Thrombosis Journal 2024 22:38
  17. Patients with acute myeloid leukemia (AML) are at increased risk of venous thromboembolic events (VTE). However, thromboprophylaxis is largely underused.

    Authors: Mirjana Mitrovic, Nikola Pantic, Zoran Bukumiric, Nikica Sabljic, Marijana Virijevic, Zlatko Pravdic, Mirjana Cvetkovic, Nikola Ilic, Jovan Rajic, Milena Todorovic-Balint, Ana Vidovic, Nada Suvajdzic-Vukovic, Jecko Thachil and Darko Antic
    Citation: Thrombosis Journal 2024 22:37
  18. In this report, we report a case of a middle-aged male, admitted to the ICU with cerebral hemorrhage resulting from a severe high-altitude fall. The patient encountered significant challenges in oxygenation in...

    Authors: Lijie Wang, Chengyong Ma, Luping Wang, Qianrong Ding, Hao Yang, Bo Wang and Qin Wu
    Citation: Thrombosis Journal 2024 22:36
  19. Older individuals and, in particular, individuals at risk of recurrent stroke, may be susceptible to thrombosis when participating in exercise, however, this aspect has not been well investigated.

    Authors: L. B. Nørregaard, K. A. Wickham, J. S. Jeppesen, N. Rytter, L. C. Christoffersen, L. Gliemann, M. Lawrence, P. A. Evans, C. Kruuse and Y. Hellsten
    Citation: Thrombosis Journal 2024 22:35
  20. To investigate the genetic underpinnings of the association between type 2 diabetes (T2D), glycemic indicators such as fasting glucose (FG), fasting insulin (FI), and glycated hemoglobin (GH), and venous throm...

    Authors: Mingyi Yang, Xianjie Wan, Yani Su, Ke Xu, Pengfei Wen, Binfei Zhang, Lin Liu, Zhi Yang and Peng Xu
    Citation: Thrombosis Journal 2024 22:33
  21. Antiphospholipid syndrome (APLS) is a systemic immune dysregulation distinguished by repetitive complications and pregnancy loss in the absence of definite etiology. Most research focuses on the laboratory det...

    Authors: Shams ElDoha Galal ElDin Zaiema, Menna Allah Zakaria Mohammad Ali Abou Elwafa, Shaymaa Gamal Arafa Hassan, Radwa Hassan Abou El Fotoh El Adwey, Raghda Mohammed Mostafa Ghorab and Raghda El Sayed Abdel Monem Galal
    Citation: Thrombosis Journal 2024 22:32
  22. The International Medical Prevention Registry for Venous Thromboembolism (IMPROVE) Bleeding Risk Score is the recommended risk assessment model (RAM) for predicting bleeding risk in acutely ill medical inpatie...

    Authors: Daichi Arakaki, Mitsunaga Iwata and Teruhiko Terasawa
    Citation: Thrombosis Journal 2024 22:31
  23. Thromboembolic complications are well known in the treatment of childhood acute lymphoblastic leukemia. Over the years it has not been possible to reach a consensus on a possible prophylaxis of thromboembolic ...

    Authors: Christina Salvador, Robert Salvador, Gabriele Kropshofer, Bernhard Meister, Marie Rock, Petra Obexer, Benjamin Hetzer, Evelyn Rabensteiner and Roman Crazzolara
    Citation: Thrombosis Journal 2024 22:30
  24. Thrombosis in ANCA-associated vasculitis (AAV) was prevalent and has been neglected in Chinese patients. This study tried to describe the clinical characteristics, identify the risk factors, and investigate th...

    Authors: Xin Chen, Shuo Zhang, Ruilian You, Yixin Ma, Peng Xia, Xiaoxiao Shi, Haiting Wu, Ke Zheng, Yan Qin, Xinping Tian and Limeng Chen
    Citation: Thrombosis Journal 2024 22:29
  25. C-type lectin-like receptor-2 (CLEC-2) is a member of the C-type lectin superfamily of cell surface receptors. The first confirmed endogenous and exogenous ligands of CLEC-2 are podoplanin and rhodocytin, resp...

    Authors: Lan Sun, Zhe Wang, Zhiyan Liu, Guangyan Mu, Yimin Cui and Qian Xiang
    Citation: Thrombosis Journal 2024 22:27
  26. Analyses of extensive, nationally representative databases indicate a rising prevalence of venous thromboembolism (VTE) among critically ill children. However, the majority of studies on childhood VTE have pri...

    Authors: Jintuo Zhou, Yanting Zhu, Ying Liu, Hairong Zhan, Peiguang Niu, Huajiao Chen and Jinhua Zhang
    Citation: Thrombosis Journal 2024 22:26
  27. The retrieval of inferior vena cava (IVC) filter is essential for preventing complications associated with the device. Advanced techniques have been developed to improve the success rate of retrieving tip-embe...

    Authors: Yang Liu, Junlong Ma, Qiqi Wang, Wei Zeng and Chunshui He
    Citation: Thrombosis Journal 2024 22:25
  28. There are situations where information about the anticoagulant effects of Rivaroxaban could be clinically useful. Methods for measuring Rivaroxaban concentrations are not available at all medical laboratories ...

    Authors: Liselotte Onelöv, Elvar Theodorsson, Mojca Božič-Mijovski† and Alenka Mavri
    Citation: Thrombosis Journal 2024 22:24
  29. Left ventricular thrombus (LVT) formation in patients with acute myocardial infarction (AMI) or cardiomyopathies is not uncommon. The optimal oral anticoagulation therapy for resolving LVT has been under inten...

    Authors: Tong Hu, Changli Chen, Kellina Maduray, Wenqiang Han, Tongshuai Chen and Jingquan Zhong
    Citation: Thrombosis Journal 2024 22:23
  30. There is substantial evidence to support the use of several methods for preventing deep-vein thrombosis (DVT) following intracerebral hemorrhage (ICH). However, the extent to which these measures are implement...

    Authors: Ran Zhang, Weige Sun, Yana Xing, Yongjun Wang, Zixiao Li, Liping Liu, Hongqiu Gu, Kaixuan Yang, Xin Yang, Chunjuan Wang, Qingbo Liu, Qian Xiao and Weixin Cai
    Citation: Thrombosis Journal 2024 22:22
  31. This study aimed to analyze the independent risk factors contributing to preoperative DVT in TKA and constructed a predictive nomogram to accurately evaluate its occurrence based on these factors.

    Authors: Zehua Wang, Xingjia Mao, Zijian Guo, Guoyu Che, Changxin Xiang and Chuan Xiang
    Citation: Thrombosis Journal 2024 22:21
  32. Inherited thrombophilia (IT) has a complex pathophysiology and is associated with recurrent miscarriage (RM) by causing placental insufficiency and inhibiting fetal development. However, thrombophilia screenin...

    Authors: Ayman A. Najjar, Imam Hassouna, Mahmoud A. Srour, Hany M. Ibrahim, Randa Y. Assi and Heba M. Abd El Latif
    Citation: Thrombosis Journal 2024 22:20
  33. Antithrombin (AT) is an important anticoagulant in hemostasis. We describe here the characterization of a novel AT mutation associated with clinically relevant thrombosis. A pair of sisters with confirmed type...

    Authors: Maximilian Ruf, Sarah Cunningham, Alexandra Wandersee, Regine Brox, Susanne Achenbach, Julian Strobel, Holger Hackstein and Sabine Schneider
    Citation: Thrombosis Journal 2024 22:19
  34.  We previously conducted a primary survey of pregnant women with hereditary thrombophilia based on national surveillance in Japan, but did not examine their thrombosis-related characteristics. Antithrombin (AT...

    Authors: Takao Kobayashi, Kazuko Sugiura, Toshiyuki Ojima, Mariko Serizawa, Kyuya Hirai and Eriko Morishita
    Citation: Thrombosis Journal 2024 22:18
  35. Patients with venous thromboembolism (VTE) comorbid renal insufficiency (RI) are at higher risk of bleeding and thrombosis. Recommendations in guidelines on anticoagulation therapy for those patients remain am...

    Authors: Shuangshuang Ma, Guohui Fan, Feiya Xu, Xiaomeng Zhang, Yinong Chen, Yuzhi Tao, Yishan Li, Yanshuang Lyu, Peiran Yang, Dingyi Wang, Zhenguo Zhai and Chen Wang
    Citation: Thrombosis Journal 2024 22:17
  36. Causes of death after first time community-acquired venous thromboembolism (VTE) diagnosed in unselected patients at the emergency department (ED) was investigated.

    Authors: Frida Lonnberg, Andreas Roos, Maria Farm, André Heurlin, Mantas Okas, Bruna Gigante and Anwar J Siddiqui
    Citation: Thrombosis Journal 2024 22:16
  37. Identifying venous thromboembolism (VTE) is challenging for patients with cardiovascular diseases due to similar clinical presentation. Most hospital-acquired VTE events are preventable, whereas the implementa...

    Authors: Qin Luo, Xin Li, Zhihui Zhao, Qing Zhao, Zhihong Liu and Weixian Yang
    Citation: Thrombosis Journal 2024 22:15
  38. Microbial infection has been associated with thrombogenesis. This study aimed to detect bacterium-specific genes and other signatures in thrombi from patients with acute ischemic stroke and to relate these sig...

    Authors: Xiaoke Wang, Jie Gao, Yantong Chen, Xiaohao Zhang, Zhengze Dai, Qiliang Dai, Mengna Peng, Lulu Xiao, Xuerong Jia, Haodi Cai, Tao Mou, Xiang Li and Gelin Xu
    Citation: Thrombosis Journal 2024 22:14
  39. A 28-year-old man diagnosed with triple positive antiphospholipid syndrome (APS) and undergoing warfarin experienced three separate admissions to the cardiac ward within a one-month period due to escalating ch...

    Authors: Ai Phi Thuy Ho, Eirik Tjønnfjord, Oliver Meyerdierks and Ellen Elisabeth Brodin
    Citation: Thrombosis Journal 2024 22:13
  40. Sepsis is a global public health burden. Deep vein thrombosis (DVT) is the third most common cause of death from cardiovascular disease after heart attacks and strokes. We designed this experiment to investiga...

    Authors: Lu Wang, Xudong Ma, Yujie Chen, Sifa Gao, Wei Pan, Jieqing Chen, Longxiang Su, Huaiwu He, Yun Long, Chang Yin and Xiang Zhou
    Citation: Thrombosis Journal 2024 22:11
  41. Disseminated intravascular coagulation (DIC) syndrome is a highly lethal condition characterized by the complication of multiple organ damage. Although the effects of combined antithrombin (AT) and recombinant...

    Authors: Takaaki Totoki, Yuto Makino, Kazuma Yamakawa, Hiroyuki Koami, Takeshi Wada, Takashi Ito and Toshiaki Iba
    Citation: Thrombosis Journal 2024 22:10
  42. Oxidative stress is an imbalance between the body’s reactive oxygen species and antioxidant defense mechanisms. Oxidative stress is involved in the development of several cardiovascular diseases, such as pulmo...

    Authors: Jingchao Yang, Jinzhu Xu, Shuanglan Xu, Zeqin Fan, Chenshao Zhu, Jianyuan Wan, Jiao Yang and Xiqian Xing
    Citation: Thrombosis Journal 2024 22:9

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    107 days submission to accept (Median)

    2023 Usage 
    708,004 downloads
    943 Altmetric mentions